Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Hospitals and Health Care
CardiAction is a Hospitals and Health Care brand in Melbourne, VIC. It is privately held, and its site is cardiaction.com. It holds three addresses on record, all in Australia. Headcount on record is 5. Its work is tagged health screening. One Australian registration (ABN) is a confirmed match. It is listed alongside seven similar brands, mostly in Health and Human Services.
ABN41619022141
| CARDIACTION PTY LTD | ABN 41619022141 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
CardiAction PreScreen: A non-invasive (no blood test required) mass population cardiovascular event risk assessment platform. How identifying the unidentified can reduce the impact of Cardiovascular Disease (CVD) on our populations and the health system.
CardiAction ProScreen: An in-person, non-invasive cardiovascular risk assessment performed in pharmacies across Australia and New Zealand. Using advanced biometric telemetry and the CardiAction proprietary dynamic algorithm, ProScreen provides real-time insights into heart and artery health without the need for blood tests or radiation.
Cardiovascular disease (CVD) is the #1 cause of death and continues to be responsible for 1/3rd of all deaths worldwide. Responsible for 44,000 deaths annually in Australia and 20 million globally.
The Key Advantages of CardiAction The CardiAction Risk Score is a dynamic algorithm that integrates key biomarkers such as age, gender, height, waist circumference, heart rate, and blood pressure data. The model incorporates central systolic blood pressure (cSBP), a recognised predictor of cardiovascular events, such as heart attack and stroke.
When using CardiAction PreScreen, cSBP is predicted with approximately ~80% accuracy based on self-reported and estimated biometrics. When using CardiAction ProScreen, cSBP is directly measured with ~99% accuracy in person using Pulse Wave Analysis (PWA). Both methods provide insight into arterial wall stiffness and inflammation. Research has shown that central blood pressure correlates more strongly with vascular disease and clinical outcomes than traditional brachial (arm) blood pressure.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Victoria entity on the ABR: CARDIACTION PTY LTD (ABN 41 619 022 141), high confidence.
5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Three addresses on record, Australia only. Primary: Melbourne, VIC 3000.
None linked to this brand.
Four tags on the brand's own list, among them health screening.
8 profiles list CardiAction as a peer — 85th percentile in Hospitals and Health Care. It lists ten peers of its own. Dreamoro Group and Health Innovators Circle list it back.